title: The promise and challenges of targeting RSK for the treatment of cancer.
authors.affiliation: University of British Columbia, Vancouver, Canada. anna.stratford@gmail.com
authors.forename: Anna L
authors.initials: AL
authors.lastname: Stratford
authors.forename: Sandra E
authors.initials: SE
authors.lastname: Dunn
mesh_terms: D000818:Animals; D000970:Antineoplastic Agents / Q000494:pharmacology*; D016503:Drug Delivery Systems; D006801:Humans; D009369:Neoplasms / Q000188:drug therapy* / Q000503:physiopathology; D047428:Protein Kinase Inhibitors / Q000494:pharmacology; D038744:Ribosomal Protein S6 Kinases, 90-kDa / Q000037:antagonists & inhibitors* / Q000378:metabolism
chemical_list: D000970:Antineoplastic Agents; D047428:Protein Kinase Inhibitors; D038744:Ribosomal Protein S6 Kinases, 90-kDa